These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 4082114

  • 1. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise.
    Estellés A, Tormo G, Aznar J, España F, Tormo V.
    Thromb Res; 1985 Nov 01; 40(3):373-83. PubMed ID: 4082114
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Severity of coronary artery disease and basal fibrinolysis.
    Small M, Lowe GD, Beattie JM, Hutton I, Lorimer AR, Forbes CD.
    Haemostasis; 1987 Nov 01; 17(5):305-11. PubMed ID: 2444504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F, Morale M, Puccetti R, De Negri F, Monzani F, Navalesi R, Mariani G.
    Thromb Res; 1992 Sep 15; 67(6):643-54. PubMed ID: 1440530
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA, Gálvez MM, Cornudella R, Angós JA, Romero MS, Gutiérrez M.
    Sangre (Barc); 1994 Apr 15; 39(2):111-6. PubMed ID: 8059288
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the fibrinolytic system in full-term neonates.
    Pinacho A, Páramo JA, Ezcurdia M, Rocha E.
    Int J Clin Lab Res; 1995 Apr 15; 25(3):149-52. PubMed ID: 8562978
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
    Rydzewski A, Sakata K, Kobayashi A, Yamazaki N, Urano T, Takada Y, Takada A.
    Haemostasis; 1990 Apr 15; 20(5):305-12. PubMed ID: 2127039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Coagulation and fibrinolytic systems in type I diabetes: effects of venous occlusion and insulin-induced hypoglycaemia.
    Wieczorek I, Pell AC, McIver B, MacGregor IR, Ludlam CA, Frier BM.
    Clin Sci (Lond); 1993 Jan 15; 84(1):79-86. PubMed ID: 8382139
    [Abstract] [Full Text] [Related]

  • 18. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I, Zietek Z, Kotschy M, Rość D, Tyloch F.
    Pol Tyg Lek; 1996 Feb 15; 51(6-9):91-3. PubMed ID: 8756741
    [Abstract] [Full Text] [Related]

  • 19. Hemostatic alterations with exercise conditioning in NIDDM.
    Hornsby WG, Boggess KA, Lyons TJ, Barnwell WH, Lazarchick J, Colwell JA.
    Diabetes Care; 1990 Feb 15; 13(2):87-92. PubMed ID: 2112452
    [Abstract] [Full Text] [Related]

  • 20. Acute hypoxemia does not increase blood fibrinolytic activity in man.
    Stegnar M, Peternel P, Chen JP.
    Thromb Res; 1987 Feb 15; 45(4):333-43. PubMed ID: 3576520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.